These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33072932)

  • 1. Duchenne Muscular Dystrophy Newborn Screening, a Case Study for Examining Ethical and Legal Issues for Pilots for Emerging Disorders: Considerations and Recommendations.
    Lloyd-Puryear MA; Crawford TO; Brower A; Stephenson K; Trotter T; Goldman E; Goldenberg A; Howell RR; Kennedy A; Watson M
    Int J Neonatal Screen; 2018 Mar; 4(1):6. PubMed ID: 33072932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Roadmap to Newborn Screening for Duchenne Muscular Dystrophy.
    Al-Zaidy SA; Lloyd-Puryear M; Kennedy A; Lopez V; Mendell JR
    Int J Neonatal Screen; 2017 Jun; 3(2):8. PubMed ID: 31588416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy.
    Wood MF; Hughes SC; Hache LP; Naylor EW; Abdel-Hamid HZ; Barmada MM; Dobrowolski SF; Stickler DE; Clemens PR
    Muscle Nerve; 2014 Jun; 49(6):822-8. PubMed ID: 24307279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care.
    Armstrong N; Schrader R; Fischer R; Crossnohere N
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):162-168. PubMed ID: 35932090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy.
    Farrar MA; Kariyawasam D; Grattan S; Bayley K; Davis M; Holland S; Waddel LB; Jones K; Lorentzos M; Ravine A; Wotton T; Wiley V;
    J Neuromuscul Dis; 2023; 10(1):15-28. PubMed ID: 36373292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot.
    Hartnett MJ; Lloyd-Puryear MA; Tavakoli NP; Wynn J; Koval-Burt CL; Gruber D; Trotter T; Caggana M; Chung WK; Armstrong N; Brower AM
    Int J Neonatal Screen; 2022 Sep; 8(4):. PubMed ID: 36278620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy.
    Ross LF
    Am J Med Genet A; 2006 Apr; 140(8):914-22. PubMed ID: 16528755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-year follow-up of newborn screening for patients with muscular dystrophy.
    Chung J; Smith AL; Hughes SC; Niizawa G; Abdel-Hamid HZ; Naylor EW; Hughes T; Clemens PR
    Muscle Nerve; 2016 Apr; 53(4):570-8. PubMed ID: 26260293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment.
    Ke Q; Zhao ZY; Griggs R; Wiley V; Connolly A; Kwon J; Qi M; Sheehan D; Ciafaloni E; Howell RR; Furu P; Sazani P; Narayana A; Gatheridge M
    World J Pediatr; 2017 Jun; 13(3):197-201. PubMed ID: 28466241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal.
    Kwon JM; Abdel-Hamid HZ; Al-Zaidy SA; Mendell JR; Kennedy A; Kinnett K; Cwik VA; Street N; Bolen J; Day JW; Connolly AM
    Muscle Nerve; 2016 Aug; 54(2):186-91. PubMed ID: 27170260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique Burdens of Pediatric Clinical Trials in Duchenne Muscular Dystrophy, April 20-21, 2017, Bethesda, Maryland, USA.
    Franson T; Kinnett K; Cripe TP
    Ther Innov Regul Sci; 2019 Jan; 53(1):154-163. PubMed ID: 29714576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it the right time for an infant screening for Duchenne muscular dystrophy?
    Vita GL; Vita G
    Neurol Sci; 2020 Jul; 41(7):1677-1683. PubMed ID: 32112218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP
    Timonen A; Lloyd-Puryear M; Hougaard DM; Meriö L; Mäkinen P; Laitala V; Pölönen T; Skogstrand K; Kennedy A; Airenne S; Polari H; Korpimäki T
    Int J Neonatal Screen; 2019 Sep; 5(3):27. PubMed ID: 33072986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story.
    Scheuerbrandt G
    Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence.
    Fraser HG; Redmond RZ; Scotcher DF
    J Genet Couns; 2018 Dec; 27(6):1349-1359. PubMed ID: 29974322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps.
    Baker M; Griggs R; Byrne B; Connolly AM; Finkel R; Grajkowska L; Haidet-Phillips A; Hagerty L; Ostrander R; Orlando L; Swoboda K; Watson M; Howell RR
    JAMA Neurol; 2019 Aug; 76(8):978-983. PubMed ID: 31107518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.